CO5640087A2 - Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos - Google Patents

Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos

Info

Publication number
CO5640087A2
CO5640087A2 CO05058244A CO05058244A CO5640087A2 CO 5640087 A2 CO5640087 A2 CO 5640087A2 CO 05058244 A CO05058244 A CO 05058244A CO 05058244 A CO05058244 A CO 05058244A CO 5640087 A2 CO5640087 A2 CO 5640087A2
Authority
CO
Colombia
Prior art keywords
inflammatory
decongestionantes
pharmacos
histaminic
compositions
Prior art date
Application number
CO05058244A
Other languages
English (en)
Inventor
Roger Glen Berlin
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32682029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5640087(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CO5640087A2 publication Critical patent/CO5640087A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

1.- Una composición farmacéutica caracterizada porque comprende una cantidad efectiva de cada uno de (a) un fármaco anti-inflamatorio no esteroideo (NSAID), (b) un descongestionante; y (c) un antihistamínico, en donde la cantidad efectiva del descongestionante o el antihistamínico o ambos, es menor de aproximadamente 75% de una cantidad presente en una dosis aprobada del descongestionante o antihistamínico, o ambos, con relación a una cantidad del fármaco anti-inflamatorio no esteroideo correspondiente a aproximadamente 100% de la cantidad presente en una forma de dosis aprobada, de fuerza normal, del fármaco anti-inflamatorio no esteroideo.
CO05058244A 2002-12-18 2005-06-15 Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos CO5640087A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43434202P 2002-12-18 2002-12-18

Publications (1)

Publication Number Publication Date
CO5640087A2 true CO5640087A2 (es) 2006-05-31

Family

ID=32682029

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05058244A CO5640087A2 (es) 2002-12-18 2005-06-15 Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos

Country Status (19)

Country Link
US (1) US7863287B2 (es)
EP (1) EP1572206B1 (es)
JP (1) JP2006515299A (es)
CN (2) CN102406642B (es)
AR (1) AR042543A1 (es)
AU (1) AU2003301188B2 (es)
CA (1) CA2508611C (es)
CL (1) CL2003002653A1 (es)
CO (1) CO5640087A2 (es)
ES (1) ES2468217T3 (es)
HK (2) HK1078494A1 (es)
MX (1) MXPA05006331A (es)
NZ (1) NZ540289A (es)
PE (2) PE20040973A1 (es)
PT (1) PT1572206E (es)
RU (1) RU2322262C2 (es)
TW (1) TWI313598B (es)
WO (1) WO2004056320A2 (es)
ZA (1) ZA200504908B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007073702A2 (es) 2005-12-29 2007-07-05 Osmotica Corp. Comprimido multicapa con combinación de triple liberación
WO2008114280A1 (en) * 2007-03-21 2008-09-25 Lupin Limited Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
CN102264358A (zh) * 2008-11-11 2011-11-30 博科药物化学有限公司 包含布洛芬、伪麻黄碱和扑尔敏的药物组合物
US8252330B2 (en) 2009-01-05 2012-08-28 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
CA2748783A1 (en) 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
WO2010078543A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing cetirizine pseudoephedrine, and naproxen containing a barrier layer
AU2010315561B2 (en) * 2009-10-26 2016-10-20 Sephoris Pharmaceuticals, Llc Treatment of sunburn using analgesics and antihistamines
JP5777906B2 (ja) * 2010-02-26 2015-09-09 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
EP2566478A4 (en) * 2010-05-03 2014-04-30 Tsh Biopharm Corp Ltd PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION
KR20180009813A (ko) * 2010-07-19 2018-01-29 프로갑스 에스.에이. 캡슐 내부에 캡슐 또는 다른 고형 제형을 캡슐화하는 것을 위한 장치 및 방법
JP5898963B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
JP5898964B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩を含有する医薬組成物
US9216181B2 (en) * 2011-06-08 2015-12-22 Southwest Research Institute BMP-2 upregulating compounds for healing bone tissue and screening methods for selecting such compounds
WO2014165241A1 (en) * 2013-03-12 2014-10-09 Hercules Incorporated Coprocessed silica coated polymer composition
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
US10420756B2 (en) 2015-03-26 2019-09-24 Sen-Jam Pharmaceutical Llc. Methods and compositions to inhibit symptoms associated with veisalgia
CN104758935B (zh) * 2015-04-10 2017-11-21 海口世康药物研究有限公司 一种改善复方布洛芬制剂稳定性的组合物及其制备方法
CA3038263C (en) 2016-09-26 2022-04-05 The Procter & Gamble Company Extended relief dosage form

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755532A (en) * 1984-02-08 1988-07-05 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4683243A (en) * 1984-02-08 1987-07-28 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4906625A (en) * 1984-02-08 1990-03-06 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and metyhods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4585783A (en) * 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4985459A (en) * 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4840962A (en) * 1984-04-09 1989-06-20 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
AU738274B2 (en) 1984-04-09 2001-09-13 Procter & Gamble Company, The Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4971785A (en) * 1988-03-14 1990-11-20 Spectrum Consumer Products Co., Inc. Non-alcoholic delivery system for orally ingestible active ingredients
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
WO1992004022A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
AU662297B2 (en) * 1990-09-11 1995-08-31 Richardson-Vicks Inc. Method for providing improved analgesic effect
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
CA2107331A1 (en) 1991-04-01 1992-10-02 Robert T. Sims Ibuprofen-decongestant combinations
US5492689A (en) * 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
CA2084028A1 (en) 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US6303632B1 (en) * 1992-09-03 2001-10-16 Sepracor Inc. Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients
EP0674527A1 (en) * 1992-12-21 1995-10-04 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
EP0674517A1 (en) 1992-12-21 1995-10-04 The Procter & Gamble Company Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen
CA2160368A1 (en) * 1993-06-04 1994-12-22 Stanley J. Lech Preparations containing silicon dioxide to improve the taste thereof
US5466865A (en) * 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
CA2170485C (en) * 1993-09-07 2000-11-07 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
CA2170488A1 (en) 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
JPH09509138A (ja) 1993-10-25 1997-09-16 メレルファーマスーティカルズ インコーポレイテッド ターフェナジン及びイブプロフェンの安定な製剤組成物
US5560913A (en) * 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5622723A (en) * 1995-02-03 1997-04-22 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
EP0841947A1 (en) 1995-07-28 1998-05-20 The Procter & Gamble Company Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
US5766622A (en) 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
EP1014983A1 (en) 1997-09-19 2000-07-05 The Procter & Gamble Company Naproxen/cetirizine compositions and methods for treating respiratory disorders
US6337091B1 (en) * 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
US6270796B1 (en) * 1997-10-29 2001-08-07 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
WO2003024427A1 (en) * 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
JP2002316927A (ja) 2001-04-19 2002-10-31 Taisho Pharmaceut Co Ltd 感冒用組成物
CA2448081A1 (en) 2001-05-25 2002-12-05 Minoru Okada Medicinal compositions
AU2003219348A1 (en) 2002-04-22 2003-11-03 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
JPWO2004048895A1 (ja) 2002-11-22 2006-03-23 財団法人くまもとテクノ産業財団 移動体ナビゲート情報表示方法および移動体ナビゲート情報表示装置
WO2005063219A2 (en) 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules

Also Published As

Publication number Publication date
PE20040973A1 (es) 2004-12-14
TWI313598B (en) 2009-08-21
CN102406642B (zh) 2013-04-03
ES2468217T3 (es) 2014-06-16
PT1572206E (pt) 2014-06-12
AR042543A1 (es) 2005-06-22
CA2508611A1 (en) 2004-07-08
CA2508611C (en) 2011-07-26
JP2006515299A (ja) 2006-05-25
RU2322262C2 (ru) 2008-04-20
WO2004056320A3 (en) 2004-09-23
US20040186184A1 (en) 2004-09-23
AU2003301188A1 (en) 2004-07-14
MXPA05006331A (es) 2005-08-26
CN1726035A (zh) 2006-01-25
CN102406642A (zh) 2012-04-11
WO2004056320A2 (en) 2004-07-08
NZ540289A (en) 2006-10-27
ZA200504908B (en) 2006-12-27
TW200413004A (en) 2004-08-01
US7863287B2 (en) 2011-01-04
HK1166602A1 (en) 2012-11-02
HK1078494A1 (en) 2006-03-17
PE20081072A1 (es) 2008-08-15
EP1572206B1 (en) 2014-04-23
EP1572206A4 (en) 2007-07-18
AU2003301188B2 (en) 2009-07-02
RU2005122403A (ru) 2006-01-20
EP1572206A2 (en) 2005-09-14
CL2003002653A1 (es) 2005-04-22

Similar Documents

Publication Publication Date Title
CO5640087A2 (es) Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
AR020015A1 (es) Composiciones de celecoxib
ECSP066807A (es) Formulaciones galénicas de compuestos orgánicos
MX2007007885A (es) Composiciones farmaceuticas oralmente desintegrables con agentes de indicacion sensorial.
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
ATE431738T1 (de) Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
ECSP055569A (es) Forma de dosificación de pramipexol en una dosis única diaria
ATE423556T1 (de) Capsaicin-enthaltende missbrauchsichere pharmazeutische zusammensetzungen
IL173078A0 (en) Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
CO5650230A2 (es) Composiciones estables de atorvastatina preparadas con granulacion en humedo
DE602005021475D1 (de) Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423)
ECSP003807A (es) Composiciones valdecoxib
UY28517A1 (es) Nueva combinación
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
ATE442158T1 (de) Oral verabreichte pharmazeutische zusammensetzungen mit einem abgabemittel in mikronisierter form
BR0112847A (pt) Uso de uma forma de dosagem sólida
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
PE20030830A1 (es) Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea
ATE410152T1 (de) Therapeutisches system mit amoxicillin und clavulansäure
DE60301261D1 (de) Pharmazeutische zusammensetzungen enthaltend 17alpha-furanylester von 17beta-carbothioat androstanderivaten und einen muskarinrezeptorantagonist
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
AR043370A1 (es) Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -droga

Legal Events

Date Code Title Description
FC Application refused